1. Home
  2. NEON vs INAB Comparison

NEON vs INAB Comparison

Compare NEON & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$0.82

Market Cap

13.9M

Sector

Technology

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.06

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
INAB
Founded
1997
2016
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
11.8M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
NEON
INAB
Price
$0.82
$1.06
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$6.00
AVG Volume (30 Days)
43.4K
33.8K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.88
52 Week High
$4.23
$2.73

Technical Indicators

Market Signals
Indicator
NEON
INAB
Relative Strength Index (RSI) 43.50 48.27
Support Level $0.80 $0.96
Resistance Level $0.94 $1.22
Average True Range (ATR) 0.04 0.06
MACD -0.00 -0.00
Stochastic Oscillator 19.47 38.10

Price Performance

Historical Comparison
NEON
INAB

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

Share on Social Networks: